1:15PM - 2:45PM EDT Omni King Edward Hotel, Sovereign Ballroom
DCD Donation/Current and Its Impact on Transplant
Nader Moazami, NYU Langone Health
Nader Moazami, MD is the Surgical Director of Heart Transplantation and Mechanical Circulatory support at NYU Langone Health. Dr. Moazami is a graduate of the Columbia University College of Physicians and Surgeons, New York. He served his internship and residency at Columbia-Presbyterian Medical Center in New York, and completed a fellowship in cardiothoracic surgery at Cleveland Clinic in 2001. His major areas of focus have been in Mechanical Circulatory Support and more recently on Heart transplantation.
A prolific researcher, Dr. Moazami has published more than 100 scientific articles in leading peer-reviewed journals. He has been the principal investigator on over two dozen trials of new heart assist devices and other therapies for end-stage heart failure. Additionally he serves as a reviewer for several of the heart and transplantation journals.
Dr. Moazami is a frequent speaker and instructor with more than 200 presentations and educational sessions to his credit. His professional memberships include the International Society for Heart & Lung Transplantation, Society of Thoracic Surgeons, Heart Failure Society of America, American Society for Artificial Internal Organs and American Association for Thoracic Surgery. His professional career has been dedicated to advancing the field of mechanical circulatory support and heart transplantation. His most recent accomplishments are in areas of expanding the donor pool for heart transplantation using NRP for DCD heart donations, use of hepatitis C viremic donor hearts, and ethical aspects of NRP. In summer of 2022, his team was the first in the world to complete pig-human xenotransplantation in 2 recently deceased recipients who donated their body to research.
Ashish Shah, Vanderbilt University Medical Center
Dr. Ashish S. Shah is the Alfred Blalock Director and Chair of Cardiac Surgery at Vanderbilt University Medical Center. He trained at Duke University Medical Center and served on the faculty of The Johns Hopkins Hospital for 10years before joining the faculty at Vanderbilt.
1:15PM - 2:45PM EDT Omni King Edward Hotel, Vanity Fair Ballroom
Donor Lung Preservation: What Is New?
Matthew Hartwig, Duke Hospital
Dr. Hartwig is a tenured Professor of Surgery within the Division of Thoracic and Cardiovascular Surgery at Duke University School of Medicine. He has particular clinical interests in lung transplantation, disorders of the esophagus, and robotic technology utilization in thoracic surgery.
Shaf Keshavjee, Toronto General Hospital, University Health Network
Dr. Shaf Keshavjee completed his medical training at the University of Toronto in 1985, and subsequently trained in General Surgery, Cardiac Surgery and Thoracic Surgery at the University of Toronto followed by fellowship training at Harvard University and the University of London for airway surgery and heart-lung transplantation, respectively. He leads a team whose studies in transplantation have had a significant impact on treatment outcomes for patients with lung disease around the world. Dr. Keshavjee is currently Chief of Innovation at University Health Network, University of Toronto.
An integral part of the Division of Thoracic Surgery at UHN, Dr. Keshavjee has taken on leadership roles in all facets of this specialized area of care: as a skilled surgeon and Director of the Toronto Lung Transplant Program; and as a researcher and Director of the Latner Thoracic Research Laboratories. To improve lung function after transplantation, he developed a lung preservation solution to preserve donor lungs for transplant. This solution has become the standard technique used by transplantation programs around the world. Dr.Keshavjee has further attracted worldwide attention for his pioneering research to recondition and repair injured human donor lungs using gene and cell therapies and the Toronto Ex Vivo Lung Perfusion System, making them suitable for transplantation into patients and enhancing the number of donor lungs available.
Dr. Keshavjee has served on the Board of Directors of the ISHLT and the Canadian Society of Transplantation. He has served as a Member of the Board, Treasurer and then the 102nd President of the AATS. He has received numerous awards and honorary fellowships for his continuing contributions to his field, including several lifetime achievement awards. Dr. Keshavjee has recieved several honorary doctoral degrees, the Order of Ontario, and Canada's highest civilian honor as Officer of the Order of Canada for his contributions to medicine.
3:00PM - 5:00PM EDT Omni King Edward Hotel, Sovereign Ballroom
Current Use of MCS and Future Technology
Leora Yarboro, University of Virginia
Leora Yarboro is an associate professor of surgery at the University of Virginia. She is the surgical director of heart transplantation and mechanical circulatory support. She is certified by both the American Board of Thoracic Surgery and the American Board of Surgery.
Mark Slaughter, University of Louisville/Jewish Hospital
Mark S. Slaughter, M.D. is the Legacy Foundation of Kentuckiana Professor and Chair of the Department of Cardiovascular and Thoracic Surgery at the University of Louisville and the Cardiovascular Innovation Institute Medical Director. Dr. Slaughter serves as the Surgical Director of Heart Transplant and MCS at the UofL Heart Hospital. He is the past President of the American Society for Artificial Internal Organs and the International Society of Rotary Blood Pumps. Dr. Slaughter currently serves as a reviewer for NIH SBIR grants and is the Editor in Chief of the ASAIO Journal.
3:00PM - 5:00PM EDT Omni King Edward Hotel, Vanity Fair Ballroom
New Technology in Lung Transplantation
Ankit Bharat, Northwestern University Feinberg School of Medicine
Ankit Bharat is the Harold L. and Margaret N. Method Professor of Surgery, Chief of Thoracic Surgery, and the Executive Director of the Canning Thoracic Institute at Northwestern University in Chicago. He received medical training at Christian Medical College in India following which he joined Washington University in St Louis. There, he completed general surgery residency and cardiothoracic surgery fellowship as well as a post-doctoral research fellowship. At Northwestern, he treats patients with advanced thoracic diseases and provides therapies such as lung transplantation and extracorporeal membrane oxygenation to those with end-stage lung failure. In addition, he provides minimally invasive treatment to patients with thoracic malignancies including robotic and video-assisted thoracoscopic surgery. His NIH funded basic science laboratory investigates immunopathogenesis of lung disease with a focus on transplant immunobiology. Using research tools such as single cell transcriptomics, top-down proteomics, intravital imaging, and multichannel flow-cytometry, in combination with bioinformatics and computational biology, his research group is interested in identifying clinically actionable mechanisms underlying lung injury and utilizing models relevant to human disease. His laboratory is also interested in intravital imaging of immune responses after transplantation to determine the mechanisms of neutrophil recruitment into the lungs. He pursues problem-based surgical research by taking important clinical problems to the basic laboratory and their clinical lung transplant program allows his research team to validate their laboratory findings in humans.
No added events available on this day